4.5 Review

The relationship between pneumococcal serotypes and antibiotic resistance

期刊

VACCINE
卷 30, 期 17, 页码 2728-2737

出版社

ELSEVIER SCI LTD
DOI: 10.1016/j.vaccine.2012.01.091

关键词

Streptococcus pneumoniae; Pneumococcal; Antibiotic resistance; Pneumococcal conjugate vaccine; PCV7; Pneumococcal serotypes

资金

  1. Berna/Crucell
  2. Wyeth/Pfizer
  3. MSD
  4. Protea
  5. Pfizer Inc

向作者/读者索取更多资源

Streptococcus pneumoniae (SP) causes significant burden of disease, including invasive pneumococcal disease and noninvasive diseases such as pneumonia and acute otitis media. SP has at least 93 different capsular serotypes, with the various serotypes having different propensities for producing disease or developing antibiotic resistance. An increase in the prevalence of antibiotic-resistant SP serotypes has been observed globally. The objective of this paper was to examine the relationship between antibiotic resistance and SP serotypes, with a primary focus on studies published in the past 10 years. Changing trends in antibiotic resistance and serotype distribution during this time, including those before and after the introduction of 7-valent pneumococcal conjugate vaccine (PCV7), were analyzed. Factors that influence the prevalence of antibiotic-resistant serotypes include antibiotic selection pressure, the use of PCV7, and the emergence and spread of antibiotic-resistant clones. The emergence of multidrug resistant serotype 19A is of particular concern. Antibiotic-resistant SP is a global problem that must be addressed through multiple strategies, including national vaccination programs, antibiotic control programs, and ongoing surveillance. (c) 2012 Elsevier Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据